Mapping the Target for the MRgFUS Treatment of Tremor

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

June 15, 2022

Study Completion Date

June 15, 2022

Conditions
Tremor, EssentialParkinson's Disease
Interventions
OTHER

Automatic DRT/VIM target-recognition method using MR-SISET and ML approaches

The proposed sequence (\<15 minutes) will be added as a supplementary sequence only for the preoperative imaging for subjects who agree to participate: a 3D multi-echo GRE sequence will be performed during a preoperative MR imaging, using the following parameters: field of view = 220x170x75 mm3, matrix = 176x136x60, 1.25-mm isotropic resolution, flip angle = 22 degrees, TR = 92 ms, 20 TEs = 1.90 - 45.98 ms with echo spacing of 2.32 ms, bandwidth = 840 Hz/pixel.

OTHER

Routine clinical MRI protocol

MRI will be performed using 3T scanner (Skyra, Siemens, Erlangen, Germany). All patients will undergo preoperative MRI of the brain including routine clinical MRI protocol (T1-/T2-weighted and diffusion imaging) under general anesthesia to reduce movement artifacts.

Trial Locations (1)

10016

NYU Langone, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04661241 - Mapping the Target for the MRgFUS Treatment of Tremor | Biotech Hunter | Biotech Hunter